Schizophrenia

  • Most Topular Stories

  • Recovery in Psychosis: A Delphi Study With Experts by Experience

    Schizophrenia Bulletin - Advance Access
    Law, H., Morrison, A. P.
    12 Apr 2014 | 1:37 am
    This study aimed to establish consensus about the meaning of recovery among individuals with experience of psychosis. A Delphi approach was utilized to allow a large sample of service users to be anonymously consulted about their views on recovery. Service users were invited to take part in a 3-stage consultation process. A total of 381 participants gave their views on recovery in the main stage of this study, with 100 of these taking part in the final review stage. The final list of statements about recovery included 94 items, which were rated as essential or important by >80% of…
  • "Clozapine makes me quite drowsy, so when I wake up in the morning...

    Schizophrenia News
    16 Apr 2014 | 2:03 am
    Research has shown that individuals with schizophrenia use caffeine at higher rates than the general population; however, no qualitative research has been undertaken investigating problematic caffeine use and its effects on this population.
  • A new intervention to improve well-being in people with psychiatric disorders

    Schizophrenia News From Medical News Today
    15 Apr 2014 | 2:00 am
    The benefits of incorporating approaches from positive psychology into existing understandings of mental health problems have recently been promoted by several policy development in UK.
  • Schizoaffective Disorder

    Schiz Life
    Schiz Life
    15 Apr 2014 | 5:02 pm
    There are times when a person may be experiencing some of the symptoms of schizophrenia, but not all of them or not enough of them as sanctioned by the Diagnostic and  Statistical Manual of Mental Disorders to obtain an actual diagnosis (and in turn, the treatment needed).  And maybe they are displaying symptoms associated with other mental illnesses in addiction to some schizophrenia symptoms.  This is a complicated issue, make no mistake.  It is complex for the patient as well as the doctor.  Hopefully the person suffering will consult a psychiatrist or psychologist, someone who is…
  • A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia

    Schizophrenia Research
    H.Y. Meltzer, J.-P. Lindenmayer, J. Kwentus, D.B. Share, R. Johnson, K. Jayathilake
    13 Mar 2014 | 5:00 pm
    Abstract: It has been suggested that atypical antipsychotic drugs (A-APDs) other than clozapine may be effective to improve positive symptoms in some patients with treatment resistant schizophrenia (TRS), if both the dose is higher, and the duration of the trial longer, than those which have been ineffective in non-TRS (NTRS) patients. This hypothesis was tested with long acting injectable risperidone (Risperdal Consta®, RLAI). One hundred sixty TRS patients selected for persistent moderate–severe delusions or hallucinations, or both, were randomized to RLAI, 50 or 100mg biweekly, in a six…
 
 
  • add this feed to my.Alltop

    About.com Schizophrenia

  • Liking the effects of d-amphetamines linked to decreased risk for schizophrenia

    7 Apr 2014 | 1:31 pm
    The story: In a just published paper researchers from the University of Chicago report that a genetic predisposition toward liking the effects of amphetamines (specifically, d-amphetamine, the active ingredient of Adderall) might be associated with a decrease in the risk for schizophrenia and, incidentally, also attention deficit hyperactivity disorder (ADHD)....Read Full Post
  • Jury Finds AstraZeneca Not Liable in Drug Law Suit

    18 Mar 2010 | 9:09 am
    A court have found AstraZeneca not guilty in the case of their psychiatric drug Seroquel causing harm to users. Ted Baker, 61, had sued the drug maker, claiming that the drug, which he was taking caused his diabetes....Read Full Post
  • New Schizophrenia Drug Now Available in U.S.

    11 Jan 2010 | 7:55 am
    The pharmaceutical company Novartis has announced that the schizophrenia drug Fanapt (iloperidone) is now available to adult patients. Fanapt is an oral antipsychotic that is designed to be taken twice a day. It received FDA approval in May 2009....Read Full Post
  • Long-acting Version of Zyprexa Approved for Schizophrenia

    16 Dec 2009 | 9:00 am
    The FDA has approved a long-acting version of the drug olanzapine (Zyprexa) for use in schizophrenia. The new version only needs to be given every two to four weeks, compared to daily doses of the current version....Read Full Post
  • What influences your treatment choices?

    10 Jan 2008 | 10:29 am
    People with schizophrenia follow many different paths of treatment, some effective, some not as effective. What has been your experience with the health care system since your loved one ...Read Full Post
  • add this feed to my.Alltop

    About.com Schizophrenia: What's Hot Now

  • A List of Atypical Antipsychotic Drugs Used to...

    schizophrenia.guide@about.com
    16 Apr 2014 | 4:13 am
    In the early 1990s a new class of drugs were developed to treat the psychotic symptoms of schizophrenia. These drugs, the atypical antipsychotics, have proven generally as effective as the antispychotics developed decades earlier, with fewer extrapyrimidal side effects. This list of the atypical antipsychotics provides links to drug safety information from the drug manufacturers' websites.
  • The Internal Experience of Schizophrenia

    schizophrenia.guide@about.com
    16 Apr 2014 | 4:13 am
    In schizophrenia, the most basic processes of perceiving and thinking are affected by the illness. Whether you want your loved ones to understand you better, are concerned for someone who's ill, or are simply curious, this article describes the internal experience of delusions, hallucinations, and more.
  • Who Gets Schizophrenia?

    schizophrenia.guide@about.com
    16 Apr 2014 | 4:13 am
    Although the overall incidence of schizophrenia in the United States is close to 1%, different groups have a greater or lesser likelihood of developing the illness. This article from your About Guide to Schizophrenia reviews the incidence of schizophrenia among different groups of people, which scientists are using as clues to help find the cause.
  • Living With Schizophrenia

    schizophrenia.guide@about.com
    16 Apr 2014 | 4:13 am
    Schizophrenia is a chronic disease, and you should plan for times of remission and times of relapse. Even in remission, your residual symptoms (the symptoms you continue to have even when you’re relatively well) will effect all aspects of your life. This article from your About Guide to Schizophrenia gives you concrete suggestions to help you improve you independent living skills and social relationships. Page 2.
  • What Causes Schizophrenia?

    schizophrenia.guide@about.com
    16 Apr 2014 | 4:13 am
    Developmental theories of schizophrenia explore things that may have gone wrong during fetal and infant brain development. Page 3.
 
  • add this feed to my.Alltop

    About.com Schizophrenia: Most Popular Articles

  • Delusion

    16 Apr 2014 | 5:37 am
    Definition of the term, delusion
  • The Internal Experience of Schizophrenia

    16 Apr 2014 | 5:37 am
    In schizophrenia, the most basic processes of perceiving and thinking are affected by the illness. Whether you want your loved ones to understand you better, are concerned for someone who's ill, or are simply curious, this article describes the internal experience of delusions, hallucinations, and more.
  • What are the Symptoms of Schizophrenia?

    16 Apr 2014 | 5:37 am
    Are you having experiences that seem unreal? Are you concerned about strange behavior in a loved one? Learn to understand and describe the symptoms of schizophrenia, so that you can communicate them to a doctor.
  • Epidemiology

    16 Apr 2014 | 5:37 am
    Definition of the term, epidemiology
  • How is Schizophrenia Diagnosed?

    16 Apr 2014 | 5:37 am
    The better you understand the language and the process of diagnosing schizophrenia, the better you can communicate with your doctor. Remember that only a psychologist or psychiatrist can rule out or diagnose schizophrenia.
  • add this feed to my.Alltop

    Schizophrenia Bulletin - Advance Access

  • Recovery in Psychosis: A Delphi Study With Experts by Experience

    Law, H., Morrison, A. P.
    12 Apr 2014 | 1:37 am
    This study aimed to establish consensus about the meaning of recovery among individuals with experience of psychosis. A Delphi approach was utilized to allow a large sample of service users to be anonymously consulted about their views on recovery. Service users were invited to take part in a 3-stage consultation process. A total of 381 participants gave their views on recovery in the main stage of this study, with 100 of these taking part in the final review stage. The final list of statements about recovery included 94 items, which were rated as essential or important by >80% of…
  • Oxidative/Nitrosative Stress in Psychiatric Disorders: Are We There Yet?

    O'Donnell, P., Do, K. Q., Arango, C.
    8 Apr 2014 | 8:04 am
  • The Association Between Schizophrenia and Rheumatoid Arthritis: A Nationwide Population-Based Swedish Study on Intraindividual and Familial Risks

    Sellgren, C., Frisell, T., Lichtenstein, P., Landen, M., Askling, J.
    8 Apr 2014 | 8:04 am
    Numerous studies have reported a reduced risk of rheumatoid arthritis (RA) in schizophrenia. The mechanisms are unknown, but recent genome-wide association studies of schizophrenia have shown strong associations with markers spanning the major histocompatibility complex region, indicating a possible role for adaptive immunity also in schizophrenia. In this population-based cohort study, we assess the associations between RA and schizophrenia and the extent to which any observed associations are specific to RA/schizophrenia. We then extend the assessments per RA subtype and to risks in…
  • Adolescent Self-control Predicts Midlife Hallucinatory Experiences: 40-Year Follow-up of a National Birth Cohort

    Nishida, A., Xu, K. M., Croudace, T., Jones, P. B., Barnett, J., Richards, M.
    8 Apr 2014 | 8:04 am
    Background: Associations between self-control in adolescence and adult mental health are unclear in the general population; to our knowledge, no study has investigated self-control in relation to psychotic-like symptoms. Aims: To investigate the relationship between adolescent self-control and the midlife mental health outcomes of anxiety and depression symptoms and psychotic-like experiences (PLEs), controlling for the effect of adolescent conduct and emotional problems and for parental occupational social class and childhood cognition. Methods: A population-based sample, the MRC National…
  • Th17 Pathway-Mediated Immunopathogenesis of Schizophrenia: Mechanisms and Implications

    Debnath, M., Berk, M.
    7 Apr 2014 | 1:56 am
    Schizophrenia is a highly complex and severe neuropsychiatric disorder with an unknown etiopathology. Evidence for a dysregulated immune system in both the risk for and progression of schizophrenia has recently been overwhelming. Importantly, chronic low-grade inflammation both in the periphery and central nervous system has been shown to contribute predominantly to the pathogenesis of schizophrenia in a subset of individuals. Inflammation in the central nervous system is mediated by a range of proinflammatory cytokines, resident immune cells such as microglia, and brain infiltrating…
  • add this feed to my.Alltop

    Schizophrenia Research

  • Editorial Board

    31 Mar 2014 | 5:00 pm
  • Kurt Schneider Scientific Award 2014. Call for applications

    Joachim Klosterkötter
    17 Mar 2014 | 5:00 pm
  • Using parent and youth reports from the Behavior Assessment System for Children, Second Edition to identify individuals at clinical high-risk for psychosis

    Elizabeth Thompson, Emily Kline, Gloria Reeves, Steven C. Pitts, Kristin Bussell, Jason Schiffman
    16 Mar 2014 | 5:00 pm
    Abstract: Brief self-report screening can help facilitate early identification of individuals at risk for or in early stages of psychosis. Existing screening tools focus on self-reported attenuated positive symptoms to detect potential risk; however, parent reports may also be helpful for assessing symptoms, especially in younger patients. Recent evidence has shown that the “atypicality” scale within the self-report form of the Behavior Assessment System for Children, Second Edition (BASC-2) may be useful for identifying high-risk youth within a more clinically comprehensive and…
  • A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia

    H.Y. Meltzer, J.-P. Lindenmayer, J. Kwentus, D.B. Share, R. Johnson, K. Jayathilake
    13 Mar 2014 | 5:00 pm
    Abstract: It has been suggested that atypical antipsychotic drugs (A-APDs) other than clozapine may be effective to improve positive symptoms in some patients with treatment resistant schizophrenia (TRS), if both the dose is higher, and the duration of the trial longer, than those which have been ineffective in non-TRS (NTRS) patients. This hypothesis was tested with long acting injectable risperidone (Risperdal Consta®, RLAI). One hundred sixty TRS patients selected for persistent moderate–severe delusions or hallucinations, or both, were randomized to RLAI, 50 or 100mg biweekly, in a six…
  • Abbreviated quality of life scales for schizophrenia: Comparison and utility of two brief community functioning measures

    Gagan Fervaha, George Foussias, Ishraq Siddiqui, Ofer Agid, Gary Remington
    12 Mar 2014 | 5:00 pm
    Abstract: Background: The Heinrichs-Carpenter Quality of Life Scale (QLS) is the most extensively used real-world community functioning scale in schizophrenia research. However, the extensive time required to administer it and the inclusion of items that overlap conceptually with negative symptoms limit its use across studies. The present study examined the validity and utility of two abbreviated QLS measures against the full QLS excluding negative symptom items.Method: The sample included 1427 patients with schizophrenia who completed the baseline visit in the CATIE study. The validity of…
 
  • add this feed to my.Alltop

    Schizophrenia Research - Articles in Press

  • Illness insight and neurophysiological error-processing deficits in schizophrenia - Corrected Proof

    Vinay Kansal, Iulia Patriciu, Michael Kiang
    14 Apr 2014 | 5:00 pm
    Abstract: Impaired illness insight in schizophrenia is associated with non-adherence and worse outcomes. Schizophrenia patients also exhibit error-monitoring deficits, which have been proposed to cause poor insight. To test this hypothesis, we examined whether schizophrenia patients' deficits in neurophysiological error-monitoring indices, the error-related negativity (ERN) and error positivity (Pe) event-related potential (ERP) amplitudes, are associated with impaired insight. ERPs were recorded in 18 schizophrenia patients and 18 normal comparison participants during a Stroop task.
  • A comparison of decision making in patients with bipolar i disorder and schizophrenia - Corrected Proof

    Diego J. Martino, Sergio A. Strejilevich
    14 Apr 2014 | 5:00 pm
    Currently there is a heated debate about whether bipolar disorder (BD) and schizophrenia (SZ) are separate diseases or if they are part of a neurodevelopmentally continuous model of psychosis (). Both genetic and familial studies showed that there is an overlap in genetic risk of these disorders () and neurocognitive functioning is one of the most frequently investigated endophenotypes. Neurocognitive studies consistently reported quantitative rather than qualitative differences not supporting a nosological distinction (for a review see ). A paradigm in which qualitative differences could be…
  • The effects of individually tailored formulation-based cognitive behavioural therapy in auditory hallucinations and delusions: A meta-analysis - Corrected Proof

    Mark van der Gaag, Lucia R. Valmaggia, Filip Smit
    13 Apr 2014 | 5:00 pm
    Abstract: There is no meta-analysis of cognitive behavioural therapy for delusions and hallucinations separately. The aim of this meta-analysis is to evaluate the end-of-treatment effects of individually tailored case-formulation cognitive behavioural therapy on delusions and auditory hallucinations using symptom-specific outcome measures.A systematic search of the trial literature was conducted in MEDLINE, PSYCHINFO and EMBASE. Eighteen studies were selected with symptom specific outcome measures. Hedges' g was computed and outcomes were pooled meta-analytically using the random-effects…
  • Impaired facilitation of self-control cognition by glucose in patients with schizophrenia: A randomized controlled study - Corrected Proof

    Chung-Ming Leung, William S. Stone, Edwin Ho-Ming Lee, Larry J. Seidman, Eric Yu-Hai Chen
    13 Apr 2014 | 5:00 pm
    Abstract: Objective: Studies in healthy individuals show that exerting self-control consumes cognitive resources, which reduces subsequent self-control performance. Restoring the availability of blood glucose eliminates this impairment. Patients with schizophrenia are found to have self-regulatory dysfunctions. This study aims to investigate whether patient's (a) glucose facilitation effects will be impaired, and (b) will have exaggerated depletion in a self-control task.Method: 40 patients with schizophrenia-spectrum disorders and 40 normal controls were recruited. A two drinks (glucose vs.
  • Identifying aspects of neighbourhood deprivation associated with increased incidence of schizophrenia - Corrected Proof

    Vishal Bhavsar, Jane Boydell, Robin Murray, Paddy Power
    13 Apr 2014 | 5:00 pm
    Abstract: Background: Several studies have found an association between area deprivation and incidence of schizophrenia. However, not all studies have concurred and definitions of deprivation have varied between studies. Relative deprivation and inequality seem to be particularly important, but which aspects of deprivation or how this effect might operate is not known.Methods: The Lambeth Early Onset case register is a database of all cases of first episode psychosis aged 16 to 35years from the London Borough of Lambeth, a highly urban area. We identified 405 people with first onset…
  • add this feed to my.Alltop

    Schizophrenia News -- ScienceDaily

  • Protein researchers closing in on the mystery of schizophrenia

    11 Apr 2014 | 7:31 am
    Schizophrenia is a severe disease for which there is still no effective medical treatment. In an attempt to understand exactly what happens in the brain of a schizophrenic person, researchers have analyzed proteins in the brains of rats that have been given hallucinogenic drugs. This may pave the way for new and better medicines.
  • Researchers search for earliest roots of psychiatric disorders

    10 Apr 2014 | 9:21 am
    A single molecular mechanism in the developing brain has been identified that sheds light on how cells may go awry when exposed to a variety of different environmental insults. The findings suggest that different types of stressors prenatally activate a single molecular trigger in brain cells that may make exposed individuals susceptible to late-onset neuropsychiatric disorders.
  • Genetic predisposition to liking amphetamine reduces risk of schizophrenia, ADHD

    7 Apr 2014 | 12:38 pm
    Genetic variants associated with enjoying the effects of d-amphetamine -— the active ingredient in Adderall -— are also associated with a reduced risk for developing schizophrenia and attention deficit hyperactivity disorder (ADHD), report scientists. "Some of the variants that make you like amphetamine also appear to make you less likely to develop schizophrenia and ADHD," said study leader. "Our study provides new insights into the biology of amphetamine and how it relates to the biology of risk for these psychiatric diseases."
  • Dopamine, hippocampus and psychiatric diseases: Clarifying their relationships

    3 Apr 2014 | 10:23 am
    The role that dopamine plays in a region of the brain called the hippocampus has been demonstrated for the first time. Dopamine is a neurotransmitter that plays a central role in brain function, and many mental illnesses involve an imbalance in this chemical. Research has shown in particular that dopamine is present in the hippocampus -- the brain area associated with memory and learning -- and that it plays a key role in this region.
  • Noisy brain signals: How schizophrenic brain misinterprets the world

    2 Apr 2014 | 8:00 am
    Certain errors in visual perception in people with schizophrenia are consistent with interference or 'noise' in a brain signal known as a corollary discharge, a new study shows. Schizophrenia is a disorder that interferes with the ability to think clearly and to manage emotions. People with schizophrenia often attribute their own thoughts and actions to external sources, as in the case of auditory hallucinations. Other common symptoms include delusions and disorganized thinking and speech.
 
  • add this feed to my.Alltop

    Schizophrenia Society of Nova Scotia

  • Mind Your Health - Antigonish, Nova Scotia

    16 Apr 2014 | 4:00 am
    TODAY, April 16th, 2:00 pmAntigonish, Nova ScotiaPlease click on the image to magnify it.To download the PDF version of the above poster, please click here.Also see:GASHA - Mental Health Services
  • Genes & Environment: Children & Youth at Risk -- Treatment and Prevention of Mental Health Problems

    16 Apr 2014 | 3:30 am
    TODAY, April 16th, 7:00 pmThe Nook on Gottingen2116 Gottingen StreetHalifax, Nova ScotiaPlease click on the image to magnify it.To download the PDF version of the poster, please click here. For further information on this event, please click here.
  • Clara Hughes and Clara's Big Ride - New Glasgow, Nova Scotia

    16 Apr 2014 | 3:00 am
    TODAY, April 16th, 7:00 pmNew Glasgow, Nova ScotiaSOLD OUTPlease click on the image to magnify it.To download the PDF version of the above poster, please click here.Note: Doors open at 6:00 pm for silent auction and refreshments.Also see:Facebook Event PageClara's Big Ride for Bell Let's Talk
  • Kings County Chapter of the SSNS

    16 Apr 2014 | 2:30 am
    TODAY, April 16th, 7:00 pm Meetings of the Kings County Chapter of the Schizophrenia Society of Nova Scotia are generally held the third Wednesday of each month, beginning at 7:00 pm, at the Louis Millet Community Complex, Room 121 (east entrance), 9489 Commercial Street, New Minas, Nova Scotia. Meetings are not held during the summer months of July and August.  To contact the Kings County Chapter, please send an email to kcschizsoc@outlook.com.Also see: Kings County Chapter of the SSNSKings County Chapter brochure (PDF) Support for Family and Friends of Persons Living with Mental…
  • The "From Recovery to Discovery" Mental Health Peer Support Group - Halifax

    16 Apr 2014 | 2:00 am
    Tomorrow, April 17th, 6:30 pmMeetingsEvery Thursday Evening6:30 pm to 8:30 pmCommunity RoomAtlantic Superstore – Barrington Street 1075 Barrington StreetHalifax, Nova Scotia Plenty of free parking!The Atlantic Superstore – Barrington Street is on the 3, 7, 9, and 41 Metro Transit bus routes.The From Recovery to Discovery Mental Health Peer Support Group is open to anyone affected by any type of mental illness, and this includes family members and friends.Free! Thursday, April 17th, 2014, 6:30 pmDrama Therapy for Mental Health withLaura Burke, MAProject CoordinatorDrama Therapy…
  • add this feed to my.Alltop

    schizophrenic.com

  • If you enjoy adderall, you may have a decreased risk of developing schizophrenia

    Mara Tyler
    10 Apr 2014 | 1:49 pm
    Certain genetic variants that make a person enjoy the effects caused by d-amphetamine, the active ingredient in Adderall, could also reduce an individual's risk for developing schizophrenia or attention-deficit/hyperactivity disorder (ADHD), a new study reports. A team from the University of Chicago Medical Center who conducted the research say the results support the idea that dopamine, a neurotransmitter that is effected by amphetamine, is related to schizophrenia and ADHD. "Our study provides new insights into the biology of amphetamine and how it relates to the biology of risk for these…
  • Mental health patients: What if you could read your doctor's notes?

    Mara Tyler
    8 Apr 2014 | 9:02 am
    In any routine session with a psychiatrist, social worker or mental health care provider, it's common for doctors and therapists to take notes on their patients. But what if, at the end of the session, patients could see these notes? While it's standard practice to usually only share this information with other doctors, clinicians at Beth Israel Deaconess Medical Center have started posting their notes in patients' online electronic files - where they are accessible for patients to read at will. A strategy for improved care Dr. Michael Kahn, a psychiatrist at Beth Israel Deaconess, said that…
  • Is that my thought - or did someone put it there? How neural dysfunction is linked to schizophrenia symptons

    Mara Tyler
    4 Apr 2014 | 12:57 pm
    A mechanism in the brain that's responsible for monitoring one's action might explain why schizophrenics experience auditory or visual hallucinations, according to researchers at the Montreal Neurological Institute and Hospital. A brain signal known as corollary discharge happens when a nervous system message is sent to other parts of the brain to alert us that we are doing something, said lead study investigator Christopher Pack, Ph.D. “For example, if we want to move our arm, the motor area of the brain sends a signal to the muscles to produce a movement," Pack explained. "A copy of this…
  • A cancer drug shows promise for reversing schizophrenia in mice

    Mara Tyler
    1 Apr 2014 | 7:11 am
    Researchers from Johns Hopkins found that an experimental cancer drug could help restore lost brain cell function in mice that show symptoms similar to schizophrenia. Part of a class of compounds called PAK inhibitors, FRAX486 seems to stop the "pruning" process that occurs in the schizophrenic brain, where critical neural connections are destroyed. In mice, the drug was able to help partially restore these neurons so they could connect to nerve cells. "By using this compound to block excess pruning in adolescent mice, we also normalized the behavior deficit," study leader Akira Sawa, M.D.,…
  • Cascade Behavioral Hospital

    victoria1981
    30 Mar 2014 | 7:22 pm
    Cascade Behavioral Hospital has been serving our community and those struggling with schizophrenia, helping them return to their highest level of functioning and get their life back on track. Our mission is to provide world-class treatment to adults and senior adults who are struggling with schizophrenia by using a multidisciplinary approach that takes into consideration all needs of our clients. Located in Tukwilla, Washington, Cascade Behavioral Health provides empirically-validating, life-changing treatments for schizophrenia that address all the needs of the adult or older adult. Our…
  • add this feed to my.Alltop

    Schiz Life

  • Schizoaffective Disorder

    Schiz Life
    15 Apr 2014 | 5:02 pm
    There are times when a person may be experiencing some of the symptoms of schizophrenia, but not all of them or not enough of them as sanctioned by the Diagnostic and  Statistical Manual of Mental Disorders to obtain an actual diagnosis (and in turn, the treatment needed).  And maybe they are displaying symptoms associated with other mental illnesses in addiction to some schizophrenia symptoms.  This is a complicated issue, make no mistake.  It is complex for the patient as well as the doctor.  Hopefully the person suffering will consult a psychiatrist or psychologist, someone who is…
  • A Review of the TED Talk “The Voices in My Head” by Eleanor Longden

    Schiz Life
    26 Mar 2014 | 12:10 pm
    Eleanor Longden overcame her diagnosis of schizophrenia to the disbelief of the many psychiatric doctors who attempted to treat her over the years.  These were the doctors that Eleanor said “took a grim view of the voices interpreting everything I said through latent insanity.”  She was given a diagnosis of schizophrenia and saw many hospitalizations.  She even had one doctor tell her “she’d be better off with cancer because cancer was easier to cure than schizophrenia”.You may be able to relate to the sense of “toxic hopelessness and despair” she…
  • The Schizophrenia Stethoscope

    Schiz Life
    12 Mar 2014 | 12:27 pm
    So I had an idea the other night, pondering the many medical wonders we’ve created in modernity.  I love music, sound, and the physics of waves, and I began to think about stethoscopes.  I know, it was random.  But the more I ruminated, the more I began to see the stethoscope as a metaphor or model for gaining insight into our own schizophrenic situation.  How can this be?  Let’s take a look.The Stethoscope as an Insight Gaining MetaphorI feel positive that all of you are familiar with a stethoscope.  It’s the device that doctors and nurses wear around their necks when…
  • Schizophrenia and Substance Abuse

    Schiz Life
    3 Feb 2014 | 1:14 pm
    There is a strong relationship between schizophrenia and substance abuse but it may not be what you think.  Some drugs, such as psychedelics, can mimic the symptoms of schizophrenia, but there is no research suggesting that they can cause the development of schizophrenia.  Interestingly, people who suffer from this mental illness are far more likely than the general populous to develop a substance abuse problem.This is a dilemma.  A large percentage of schizophrenics are also dealing with a dual-diagnosis (also called comorbidity) of substance abuse.  This kind of misuse of prescription…
  • Marijuana and Schizophrenia: Similar Brain Problems

    Schiz Life
    24 Jan 2014 | 1:19 pm
    As it happens, many people have suspected there are psychosis related issues concerning long-term marijuana use and short-term use in those predisposed to cognitive disturbance issues.  Researchers have finally put their official stamp on the matter, stating that heavy use of this substance can lead to abnormal changes in brain structures that correlate to those found in individuals suffering from schizophrenia.The Marijuana and Schizophrenia StudyWith the staggering number of people using marijuana, especially with the number of states in the United States that are legalizing it for…
 
Log in